MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 48 filers reported holding MINERVA NEUROSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $123,000 | -75.5% | 52,822 | -69.3% | 0.00% | -100.0% |
| Q1 2021 | $502,000 | +4.1% | 172,018 | -16.5% | 0.00% | 0.0% |
| Q4 2020 | $482,000 | -17.7% | 206,104 | +11.8% | 0.00% | 0.0% |
| Q3 2020 | $586,000 | -47.4% | 184,289 | -40.4% | 0.00% | -50.0% |
| Q2 2020 | $1,115,000 | +270.4% | 308,973 | +518.3% | 0.00% | +100.0% |
| Q1 2020 | $301,000 | +254.1% | 49,971 | +319.0% | 0.00% | – |
| Q4 2019 | $85,000 | +4.9% | 11,927 | +16.0% | 0.00% | – |
| Q1 2019 | $81,000 | -26.4% | 10,278 | -37.1% | 0.00% | – |
| Q4 2018 | $110,000 | -21.4% | 16,341 | -11.1% | 0.00% | – |
| Q3 2017 | $140,000 | -54.1% | 18,386 | -46.6% | 0.00% | – |
| Q2 2017 | $305,000 | +9.3% | 34,427 | 0.0% | 0.00% | – |
| Q1 2017 | $279,000 | -31.3% | 34,427 | -0.3% | 0.00% | -100.0% |
| Q4 2016 | $406,000 | +3.3% | 34,521 | +24.0% | 0.00% | 0.0% |
| Q3 2016 | $393,000 | – | 27,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 449,500 | $1,429,000 | 0.58% |
| Opaleye Management Inc. | 767,400 | $2,440,000 | 0.48% |
| FRAZIER MANAGEMENT LLC | 550,000 | $1,749,000 | 0.16% |
| FEDERATED HERMES, INC. | 9,610,200 | $30,560,000 | 0.07% |
| Artal Group S.A. | 760,000 | $2,417,000 | 0.06% |
| ARMISTICE CAPITAL, LLC | 500,000 | $1,590,000 | 0.06% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 63,114 | $201,000 | 0.04% |
| Cormorant Asset Management, LP | 238,817 | $759,000 | 0.03% |
| ACADIAN ASSET MANAGEMENT LLC | 1,705,195 | $5,423,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 419,104 | $1,333,000 | 0.01% |